Results 1 to 10 of about 81,842 (241)

Clinical considerations and challenges in TAV-in-TAV procedures

Frontiers in Cardiovascular Medicine
Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment for aortic valve disease, including low-risk patients. However, as TAVR usage increases, concerns about long-term durability and the potential for addition interventions have
Thomas Modine
exaly   +6 more sources

TAV-in-TAV in Failed Homograft

JACC: Case Reports, 2023
A 59-year-old male patient with history of rheumatic heart disease with 3 previous surgical aortic valve replacements with the last one being homograft followed by transcatheter aortic valve implantation in failed homograft presented with severe aortic ...
Sachin S Goel
exaly   +4 more sources

BASILICA Procedure Prior to Valve-in-Valve TAVR in a Supra-Annular TAV Prosthesis

JACC: Case Reports, 2023
An 80-year-old man with a supra-annular transcatheter aortic valve (TAV) prosthesis presented with severe transvalvular aortic regurgitation 18 months after the TAV replacement procedure.
Anna Damlin, MD, PhD, Christopher Meduri, MD, PhD, Aristomenis Manouras, MD, PhD, Dinos Verouhis, MD, PhD, Rickard Linder, MD, PhD, Andreas Rück, MD, PhD, Magnus Settergren, MD, PhD   +6 more
doaj   +2 more sources

Cauliflower mosaic virus transactivator protein (TAV) can suppress nonsense-mediated decay by targeting VARICOSE, a scaffold protein of the decapping complex

Scientific Reports, 2019
During pathogenesis, viruses hijack the host cellular machinery to access molecules and sub-cellular structures needed for infection. We have evidence that the multifunctional viral translation transactivator/viroplasmin (TAV) protein from Cauliflower ...
Nina Lukhovitskaya, Lyubov A Ryabova
exaly   +2 more sources

TAV-in-TAV and Beyond

JACC: Case Reports, 2023
Maurizio Taramasso, MD, PhD, Ana Paula Tagliari, MD, PhD, David L. Fischman, MD   +2 more
doaj   +2 more sources

Differences in Severity and Prognosis Between Bicuspid and Tricuspid Severe Aortic Stenosis [PDF]

JACC: Advances
Background: Bicuspid aortic valve (BAV) often leads to aortic stenosis (AS). However, current severity assessment and treatment strategies do not differentiate between BAV and tricuspid aortic valve (TAV) patients.
Taiji Okada, MD, Takeshi Kitai, MD, Takeshi Morimoto, MD, MPH, Chisato Miyakoshi, MD, MSc, DrPH, Tomohiko Taniguchi, MD, Mitsuhiko Ota, MD, Takao Kato, MD, Kenji Ando, MD, Nobuhisa Ohno, MD, Norio Kanamori, MD, Koichiro Murata, MD, Yuichi Kawase, MD, Tatsuhiko Komiya, MD, Makoto Miyake, MD, Yoshio Arai, MD, Chisato Izumi, MD, Tadaaki Koyama, MD, Yutaka Furukawa, MD, Takeshi Kimura, MD   +18 more
doaj   +2 more sources

Viral factor TAV recruits TOR/S6K1 signalling to activate reinitiation after long ORF translation

EMBO Journal, 2011
Mikhail Schepetilnikov, Kappei Kobayashi, Lyubov A Ryabova   +2 more
exaly   +2 more sources

SAFETY CHALLENGES OF THE EUROPEAN CIVIL AVIATION IN CONDITIONS OF GLOBAL HEALTH CRISIS [PDF]

Bezbednosni Dijalozi, 2021
The COVID-19 pandemic in just a few weeks has turned the whole planet upside down: from an open accessible world we have transformed into a closed fragmented particular world separated by hard transient borders.
Tomislav Tuntev, Gjorgji Alceski
doaj   +1 more source

High-Risk TAV-in-TAV: Balloon-Expandable TAVR in a Degenerated Mechanically Expanded Valve. [PDF]

JACC Case Rep
Koskina L, Ndakotsu A, Kaliyadan A, Wang J, Iqbal SB.   +4 more
europepmc   +2 more sources

A Nanoporous 3D-Printed Scaffold for Local Antibiotic Delivery

Micromachines, 2023
Limitations of bone defect reconstruction include poor bone healing and osteointegration with acrylic cements, lack of strength with bone putty/paste, and poor osteointegration.
Pouyan Ahangar, Jialiang Li, Leslie S. Nkindi, Zohreh Mohammadrezaee, Megan E. Cooke, Paul A. Martineau, Michael H. Weber, Elie Saade, Nima Nateghi, Derek H. Rosenzweig   +9 more
doaj   +1 more source